Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human MYF5 Antibodies:
anti-Mouse (Murine) MYF5 Antibodies:
anti-Rat (Rattus) MYF5 Antibodies:
Go to our pre-filtered search.
Human Polyclonal MYF5 Primary Antibody for ELISA, WB - ABIN408728
Kuang, Kuroda, Le Grand, Rudnicki: Asymmetric self-renewal and commitment of satellite stem cells in muscle. in Cell 2007
Cow (Bovine) Polyclonal MYF5 Primary Antibody for WB - ABIN2779471
Roy, de la Serna, Imbalzano: The myogenic basic helix-loop-helix family of transcription factors shows similar requirements for SWI/SNF chromatin remodeling enzymes during muscle differentiation in culture. in The Journal of biological chemistry 2002
Show all 2 Pubmed References
Mouse (Murine) Monoclonal MYF5 Primary Antibody for ICC, IF - ABIN2668556
Harada, Okada, Odawara, Kumamaru, Saiwai, Aoki, Nakamura, Nishiyama, Ohkawa: Production of a rat monoclonal antibody specific for Myf5. in Hybridoma (2005) 2010
Pitx2c expression is rea (show PITX2 Antibodies)ctivated, while expression of Myf5 is downregulated in human systolic heart failure as determined by qRT-PCR and Western blot analyses.
results are the first demonstration of a myogenic conversion of human mesenchymal and endothelial cells by Myf5
DUX4c induces the MYF5 protein and myoblast proliferation, and has a role in facioscapulohumeral muscular dystrophy
The myogenic basic helix-loop-helix family of transcription factors, MyoD (show MYOD1 Antibodies), Myf5, myogenin (show MYOG Antibodies), and MRF4 (show MYF6 Antibodies), can each activate the muscle differentiation program.
Mrf4 (show MYF6 Antibodies) expression precedes or is contemporaneous with that of Myf5, suggesting that this transcription factor plays a hitherto unsuspected role in myogenesis
Myogenin (show MYOG Antibodies) and myogenic differentiation factor D (MyoD (show MYOD1 Antibodies)) mRNAs increased (P < 0.05) in young and old, whereas myogenic factor (show MYOG Antibodies) (myf)-5 mRNA increased in young only (P < 0.05). Myf-6 (show MYF6 Antibodies) protein increased (P < 0.05) in both young and old.
A novel homozygous polymorphism that prevented the binding of MYF-5 to FOXE1 (show FOXE1 Antibodies) promoter and affected the FOXE1 (show FOXE1 Antibodies) expression was found in 45% nonsyndromic cleft palate.
Novel RNA-binding activity of MYF5 enhances Ccnd1 (show CCND1 Antibodies) mRNA translation during myogenesis.
Transcription of the skeletal muscle program is achieved by the expression of MyoD (show MYOD1 Antibodies), which binds to the same sites as Myf5, indicating that each factor regulates distinct steps in gene initiation and transcription at a shared set of binding sites
The Myf5- and Myogenin (show MYOG Antibodies)-deficient mice showed a partial or complete, respectively, loss of TMC (show STT3A Antibodies) in an otherwise regularly structured thymus.
Elimination of Myf5(Cre)-DTA cells on a Myod (show MYOD1 Antibodies) null background did not result in the total absence of skeletal muscles
A muscle-specific (show EIF3K Antibodies) regulatory element of p57(kip2 (show CDKN1C Antibodies)) directly activated by muscle regulatory factors in myoblasts but repressed by the Notch (show NOTCH1 Antibodies) targets Hes1/Hey1 (show HEY1 Antibodies) in progenitor cells, is identified.
lineage tracing based on multiple reporter lines has demonstrated that regardless of common ancestral expression of Myf5, there is a clear distinction between periocular myogenic and non-myogenic cell lineages
The results demonstrate the heterogeneity and functional differences of the Myf5- and non-Myf5-lineage cells in the white adipose tissue.
Adult satellite cells derive from progenitors that first express the myogenic determination gene Myf5 during fetal stages of myogenesis.
Direct molecular regulation of the myogenic determination gene Myf5 by Pax3 (show PAX3 Antibodies), with modulation by Six1 (show SIX1 Antibodies)/4 factors, is exemplified by the -111 kb-Myf5 enhancer
The observations provide a mechanism linking Myf5 levels to muscle stem cell heterogeneity and fate by exposing two distinct and opposing phenotypes associated with Myf5 haploinsufficiency.
Loss of Myf5 function results in a cascade effect that begins with abnormal formation of the dorsal organizer during gastrulation, causing defects in myf5-knockdown embryos
the secreted ligand Dkk3a binds to the membrane receptor Itgalpha6b, which increases the protein level of phosphorylated p38a (show MAPK14 Antibodies) and activates myf5 promoter activity of zebrafish embryos during myogenesis.
a novel intronic microRNA, miR (show MYLIP Antibodies)-In300, which is derived from I300 of the first intron of zebrafish myf5, enables significant repression of myf5 promoter activity through silencing the long isoform of the Dickkopfs-3 gene.
A novel regulatory base sequence functions as a key element to drive the somite-specificity of myf-5.
Functional analysis of intron 1 showed a strong, negative, cis (show CISH Antibodies)-regulatory element located at +502/+835, and this is the first study to identify a novel, cis (show CISH Antibodies)-acting silencer that is crucial to negatively regulating myf-5 expression.
Foxd3 (show FOXD3 Antibodies), a well-known regulator in neural crest development, is also involved in myf5 regulation
Myf5 and Myod (show MYOD1 Antibodies) function independently during cranial myogenesis.
cell lineage-specific expression of myf5 is delicately orchestrated by multiple modules within the distal upstream region. This study provides an insight to understand the molecular control of myf5 and myogenesis in the zebrafish.
The effects of myostatin (show MSTN Antibodies) and myogenic factor 5 polymorphisms on growth and muscle traits of Marchigiana breed were assessed.
Bos taurus MYF5 activates MYF5 and MYOD1 (show MYOD1 Antibodies) expression in cultured fibroblasts.
A polymorphism showed an influence on Myf5 gene expression in the longissimus dorsi muscle
results suggest that MyoD (show MYOD1 Antibodies) and Myf5 influence the MyHC (show MYH13 Antibodies) isoform expression, although the effects are not decisive in specifying the phenotypes of adult muscles
myf5 upregulation can be a good criterion for the activation of adult myogenesis during X. laevis metamorphosis
During early Xenopus development Myf5 protein regulates a distinct myogenic program.
FGF8 (show FGF8 Antibodies), Wnt8 (show WNT8A Antibodies) and Myf5 are target genes of Tbx6 (show TBX6 Antibodies) during anteroposterior specification in Xenopus embryo
Exons and promoters are amplified and sequenced in the 5'UTR (show UTS2R Antibodies) region of this gene.
the novel SNP of the MYF5 gene within exon 1 is valuable for pig breeding.
The expression of Pitx2c (show PITX2 Antibodies), physiologically downregulated in the postnatal heart, is significantly re-activated in left ventricular failing myocardium which is associated with increased expression of a restrictive set of Pitx2 (show PITX2 Antibodies) target genes such as myf5.
Of the eight adult pig tissue types that were tested, the expression of Myf5 and MyoD1 (show MYOD1 Antibodies) was highest in the muscle tissue.
Involved in muscle differentiation (myogenic factor). Induces fibroblasts to differentiate into myoblasts. Probable sequence specific DNA-binding protein.
class C basic helix-loop-helix protein 2
, myogenic regulatory factor MYF-5
, myogenic regulatory factor 5
, Myf5 homolog
, myogenic factor 5
, MyoD family
, myogenic factor-5
, basic helix-loop-helix nuclear protein
, myogenic factor Xmyf-5